Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Piper Sandler to hold a virtual conference » 08:46
11/30/20
11/30
08:46
11/30/20
08:46
ABMD

Abiomed

$271.70 /

+8.02 (+3.04%)

, ALBO

Albireo Pharma

$36.44 /

-0.53 (-1.43%)

, ALGN

Align Technology

$475.12 /

+0.91 (+0.19%)

, ALLO

Allogene Therapeutics

$31.40 /

-0.355 (-1.12%)

, ALPN

Alpine Immune Sciences

$9.84 /

+0.59 (+6.38%)

, ALT

Altimmune

$10.60 /

+0.55 (+5.47%)

, AMRN

Amarin

$4.63 /

+0.035 (+0.76%)

, APTX

Aptinyx

$3.84 /

+0.41 (+11.95%)

, BBI

Brickell Biotech

$0.68 /

+0.0273 (+4.18%)

, MASI

Masimo

$254.28 /

+8.41 (+3.42%)

, ZBH

Zimmer Biomet

$150.10 /

+0.64 (+0.43%)

, XNCR

Xencor

$42.75 /

+1.695 (+4.13%)

, VCRA

Vocera

$34.05 /

+0.75 (+2.25%)

, ICPT

Intercept

$37.29 /

-0.01 (-0.03%)

, IMV

IMV Inc.

$3.58 /

+0.13 (+3.77%)

, OTIC

Otonomy

$4.50 /

+0.22 (+5.14%)

, OMCL

Omnicell

$106.54 /

-0.32 (-0.30%)

, NRIX

Nurix Therapeutics

$39.15 /

+0.7 (+1.82%)

, FULC

Fulcrum Therapeutics

$11.72 /

+0.42 (+3.72%)

, NCNA

NuCana

$4.50 /

+0.04 (+0.90%)

, MDT

Medtronic

$114.69 /

+1.4 (+1.24%)

32nd Annual Virtual…

32nd Annual Virtual Healthcare Conference will be held on November 30-December 3.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$150.10 /

+0.64 (+0.43%)

XNCR Xencor
$42.75 /

+1.695 (+4.13%)

VCRA Vocera
$34.05 /

+0.75 (+2.25%)

OTIC Otonomy
$4.50 /

+0.22 (+5.14%)

OMCL Omnicell
$106.54 /

-0.32 (-0.30%)

NRIX Nurix Therapeutics
$39.15 /

+0.7 (+1.82%)

MDT Medtronic
$114.69 /

+1.4 (+1.24%)

MASI Masimo
$254.28 /

+8.41 (+3.42%)

IMV IMV Inc.
$3.58 /

+0.13 (+3.77%)

ICPT Intercept
$37.29 /

-0.01 (-0.03%)

FULC Fulcrum Therapeutics
$11.72 /

+0.42 (+3.72%)

BBI Brickell Biotech
$0.68 /

+0.0273 (+4.18%)

APTX Aptinyx
$3.84 /

+0.41 (+11.95%)

AMRN Amarin
$4.63 /

+0.035 (+0.76%)

ALT Altimmune
$10.60 /

+0.55 (+5.47%)

ALPN Alpine Immune Sciences
$9.84 /

+0.59 (+6.38%)

ALLO Allogene Therapeutics
$31.40 /

-0.355 (-1.12%)

ALGN Align Technology
$475.12 /

+0.91 (+0.19%)

ALBO Albireo Pharma
$36.44 /

-0.53 (-1.43%)

ABMD Abiomed
$271.70 /

+8.02 (+3.04%)

ABMD Abiomed
$271.70 /

+8.02 (+3.04%)

10/20/20 Piper Sandler
Abiomed's TCT presentation highlights solid existing data, says Piper Sandler
08/07/20 SVB Leerink
Abiomed price target raised to $335 from $280 at SVB Leerink
07/13/20 OTR Global
Abiomed upgraded to Positive from Mixed at OTR Global
05/28/20 SVB Leerink
Abiomed price target raised to $225 from $195 at SVB Leerink
ALBO Albireo Pharma
$36.44 /

-0.53 (-1.43%)

09/10/20 Cowen
Albireo Pharma price target raised to $65 from $39 at Cowen
09/09/20 Guggenheim
Mirum Pharmaceuticals price target raised to $38 from $27 at Guggenheim
09/08/20 William Blair
William Blair says Albireo data confirms 'best-in-class' profile for odevixibat
09/08/20 Jefferies
Albireo Pharma price target raised to $79 from $50 at Jefferies
ALGN Align Technology
$475.12 /

+0.91 (+0.19%)

11/24/20 SVB Leerink
Align Technology price target raised to $520 from $460 at SVB Leerink
11/24/20 Credit Suisse
Align Technology price target raised to $515 from $432 at Credit Suisse
11/24/20 Goldman Sachs
Align Technology price target raised to $535 from $472 at Goldman Sachs
11/24/20 Baird
Align Technology price target raised to $530 from $450 at Baird
ALLO Allogene Therapeutics
$31.40 /

-0.355 (-1.12%)

11/24/20 BofA
Allogene Therapeutics initiated with a Buy at BofA
11/24/20 BofA
Allogene Therapeutics initiated with a Buy at BofA
11/04/20 Oppenheimer
Allogene weakness after abstract a buying opportunity, says Oppenheimer
11/04/20 Roth Capital
Question of safety with Allogene's Allo-CARs may be premature, says Roth Capital
ALPN Alpine Immune Sciences
$9.84 /

+0.59 (+6.38%)

08/26/20 Cowen
Alpine Immune Sciences initiated with an Outperform at Cowen
08/11/20 Piper Sandler
Alpine Immune Sciences price target lowered to $18 from $21 at Piper Sandler
06/19/20 Wedbush
Alpine Immune price target raised to $22 from $10 at Wedbush
06/18/20 Piper Sandler
Alpine Immune Sciences price target raised to $21 from $8 at Piper Sandler
ALT Altimmune
$10.60 /

+0.55 (+5.47%)

11/25/20 Piper Sandler
Phase 1 safety/immunogenicity to set Altimmune AdCOVID apart, says Piper Sandler
11/24/20 Piper Sandler
Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler
11/12/20 B. Riley Securities
Altimmune selloff on vaccine news overblown, says B. Riley Securities
10/12/20 Piper Sandler
Piper sees AdCOVID pre-clinical data helping benchmark Altimmune COVID program
AMRN Amarin
$4.63 /

+0.035 (+0.76%)

11/20/20 Piper Sandler
Piper keeps $19 target on Amarin, sees China as potential 'lucrative' market
11/05/20 Piper Sandler
Piper remains bullish about Vascepa after Amarin Q3 report, Hikma announcement
10/26/20 Piper Sandler
Piper says Amarin presentations add 'layers of compelling evidence' for Vascepa
10/15/20 Piper Sandler
Analysis of Amarin's Vascepa to drive increased market share, says Piper Sandler
APTX Aptinyx
$3.84 /

+0.41 (+11.95%)

11/19/20 H.C. Wainwright
Aptinyx price target raised to $8 from $7 at H.C. Wainwright
11/12/20 Piper Sandler
Aptinyx pipeline catalysts on track, says Piper Sandler
10/28/20 Cantor Fitzgerald
Aptinyx price target raised to $12 from $9 at Cantor Fitzgerald
10/27/20 Piper Sandler
Aptinyx initiated with an Overweight at Piper Sandler
BBI Brickell Biotech
$0.68 /

+0.0273 (+4.18%)

09/25/20 Lake Street
Approval in Japan validating for Brickell Biotech, says Lake Street
08/28/20 Lake Street
Brickell Biotech initiated with a Buy at Lake Street
08/25/20 Oppenheimer
Brickell Biotech initiated with an Outperform at Oppenheimer
MASI Masimo
$254.28 /

+8.41 (+3.42%)

11/02/20 Piper Sandler
Masimo acquisition brings 'solid opportunity,' says Piper Sandler
10/28/20 Piper Sandler
Masimo price target raised to $280 from $250 at Piper Sandler
10/06/20 Piper Sandler
Better than expected sensor utilization drove Masimo upside, says Piper Sandler
09/01/20 Baird
Masimo initiated with an Outperform at Baird
ZBH Zimmer Biomet
$150.10 /

+0.64 (+0.43%)

11/09/20 SVB Leerink
Zimmer Biomet price target raised to $167 from $160 at SVB Leerink
11/09/20 Credit Suisse
Zimmer Biomet price target raised to $106 from $99 at Credit Suisse
11/09/20 Baird
Zimmer Biomet valuation discount to peers hard to justify, says at Baird
11/09/20 Oppenheimer
Zimmer Biomet price target raised to $155 from $150 at Oppenheimer
XNCR Xencor
$42.75 /

+1.695 (+4.13%)

11/16/20 Cantor Fitzgerald
Xencor price target raised to $56 from $40 at Cantor Fitzgerald
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
07/08/20 Piper Sandler
Xencor, Atreca deal offers synergies for XmAb design, says Piper Sandler
06/22/20 Piper Sandler
Xencor's '2+1' biospecific antibodies ideal for solid tumors, says Piper Sandler
VCRA Vocera
$34.05 /

+0.75 (+2.25%)

11/10/20 Stephens
Vocera initiated with an Overweight at Stephens
10/30/20 Piper Sandler
Vocera price target raised to $41 from $28 at Piper Sandler
07/28/20
Fly Intel: Top five analyst upgrades
07/28/20 Craig-Hallum
Vocera upgraded to Buy from Hold at Craig-Hallum
ICPT Intercept
$37.29 /

-0.01 (-0.03%)

06:34 Today Citi
Intercept risk/reward favorable after pullback, says Citi
06:31 Today Citi
CymaBay price target raised to $10 from $9 at Citi
11/20/20 B. Riley Securities
Intercept price target lowered to $74 from $97 at B. Riley Securities
11/16/20 RBC Capital
RBC says new AE data on Ocaliva's Intercept 'does not reassure'
IMV IMV Inc.
$3.58 /

+0.13 (+3.77%)

07/21/20 Industrial Alliance
IMV Inc. initiated with a Buy at Industrial Alliance
07/14/20 Wells Fargo
IMV Inc. price target raised to $11 from $8.50 at Wells Fargo
05/18/20 Wells Fargo
IMV Inc. upgraded to Overweight on COVID-19 vaccine potential at Wells Fargo
05/18/20 Wells Fargo
IMV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
OTIC Otonomy
$4.50 /

+0.22 (+5.14%)

11/04/20 Piper Sandler
Piper Sandler likes risk/reward on Otonomy ahead of two readouts by year-end
07/07/20 Cantor Fitzgerald
Otonomy price target raised to $11 from $9 at Cantor Fitzgerald
07/07/20 H.C. Wainwright
Otonomy price target raised to $9 from $8 at H.C. Wainwright
06/15/20 Piper Sandler
Piper remains optimistic on Otonomy ahead of near-term clinical readouts
OMCL Omnicell
$106.54 /

-0.32 (-0.30%)

10/28/20 Craig-Hallum
Omnicell price target raised to $100 from $85 at Craig-Hallum
10/28/20 Wells Fargo
Omnicell price target raised to $84 from $74 at Wells Fargo
10/28/20 Cantor Fitzgerald
Omnicell price target raised to $95 from $90 at Cantor Fitzgerald
10/28/20 Piper Sandler
Omnicell price target raised to $86 from $70 at Piper Sandler
NRIX Nurix Therapeutics
$39.15 /

+0.7 (+1.82%)

11/24/20 Morgan Stanley
Kymera Therapeutics price target raised to $45 from $27 at Morgan Stanley
11/19/20 Baird
Baird starts Nurix Therapeutics with Outperform, $40 price target
11/18/20 Baird
Nurix Therapeutics initiated with an Outperform at Baird
08/18/20
Fly Intel: Top five analyst initiations
FULC Fulcrum Therapeutics
$11.72 /

+0.42 (+3.72%)

10/15/20 Piper Sandler
Fulcrum Therapeutics initiated with an Overweight at Piper Sandler
08/12/20
Fly Intel: Top five analyst downgrades
08/12/20 BTIG
Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG
08/12/20 Morgan Stanley
Fulcrum Therapeutics downgraded at Morgan Stanley, price target slashed to $11
NCNA NuCana
$4.50 /

+0.04 (+0.90%)

11/24/20 H.C. Wainwright
NuCana price target lowered to $15 from $17 at H.C. Wainwright
10/22/20 Truist
NuCana initiated with a Buy at Truist
10/22/20 Truist
NuCana initiated with a Buy at Truist
08/21/20 Piper Sandler
NuCana price target raised to $17 from $15 at Piper Sandler
MDT Medtronic
$114.69 /

+1.4 (+1.24%)

11/25/20 SVB Leerink
Medtronic price target raised to $123 from $111 at SVB Leerink
11/25/20 Wells Fargo
Medtronic price target raised to $135 from $127 at Wells Fargo
11/25/20 Credit Suisse
Medtronic price target raised to $126 from $118 at Credit Suisse
11/25/20 Oppenheimer
Medtronic price target raised to $128 from $122 at Oppenheimer
ZBH Zimmer Biomet
$150.10 /

+0.64 (+0.43%)

XNCR Xencor
$42.75 /

+1.695 (+4.13%)

VCRA Vocera
$34.05 /

+0.75 (+2.25%)

OTIC Otonomy
$4.50 /

+0.22 (+5.14%)

OMCL Omnicell
$106.54 /

-0.32 (-0.30%)

NRIX Nurix Therapeutics
$39.15 /

+0.7 (+1.82%)

NCNA NuCana
$4.50 /

+0.04 (+0.90%)

MDT Medtronic
$114.69 /

+1.4 (+1.24%)

MASI Masimo
$254.28 /

+8.41 (+3.42%)

ICPT Intercept
$37.29 /

-0.01 (-0.03%)

FULC Fulcrum Therapeutics
$11.72 /

+0.42 (+3.72%)

APTX Aptinyx
$3.84 /

+0.41 (+11.95%)

AMRN Amarin
$4.63 /

+0.035 (+0.76%)

ALPN Alpine Immune Sciences
$9.84 /

+0.59 (+6.38%)

ALLO Allogene Therapeutics
$31.40 /

-0.355 (-1.12%)

ALGN Align Technology
$475.12 /

+0.91 (+0.19%)

ALBO Albireo Pharma
$36.44 /

-0.53 (-1.43%)

ABMD Abiomed
$271.70 /

+8.02 (+3.04%)

  • 23
    Oct
  • 22
    Oct
  • 17
    Sep
  • 10
    Sep
  • 18
    Aug
  • 24
    Jul
  • 14
    Jul
  • 09
    Jul
  • 18
    Jun
  • 02
    Jun
  • 30
    Jan
  • 10
    Jan
MDT Medtronic
$114.69 /

+1.4 (+1.24%)

ICPT Intercept
$37.29 /

-0.01 (-0.03%)

AMRN Amarin
$4.63 /

+0.035 (+0.76%)

VCRA Vocera
$34.05 /

+0.75 (+2.25%)

OTIC Otonomy
$4.50 /

+0.22 (+5.14%)

NRIX Nurix Therapeutics
$39.15 /

+0.7 (+1.82%)

NCNA NuCana
$4.50 /

+0.04 (+0.90%)

MDT Medtronic
$114.69 /

+1.4 (+1.24%)

MASI Masimo
$254.28 /

+8.41 (+3.42%)

ICPT Intercept
$37.29 /

-0.01 (-0.03%)

FULC Fulcrum Therapeutics
$11.72 /

+0.42 (+3.72%)

APTX Aptinyx
$3.84 /

+0.41 (+11.95%)

AMRN Amarin
$4.63 /

+0.035 (+0.76%)

ALT Altimmune
$10.60 /

+0.55 (+5.47%)

ALLO Allogene Therapeutics
$31.40 /

-0.355 (-1.12%)

ALGN Align Technology
$475.12 /

+0.91 (+0.19%)

ALBO Albireo Pharma
$36.44 /

-0.53 (-1.43%)

MDT Medtronic
$114.69 /

+1.4 (+1.24%)

IMV IMV Inc.
$3.58 /

+0.13 (+3.77%)

APTX Aptinyx
$3.84 /

+0.41 (+11.95%)

AMRN Amarin
$4.63 /

+0.035 (+0.76%)

ALT Altimmune
$10.60 /

+0.55 (+5.47%)

ALGN Align Technology
$475.12 /

+0.91 (+0.19%)

Over a week ago
Initiation
Vocera initiated with an Overweight at Stephens » 16:17
11/10/20
11/10
16:17
11/10/20
16:17
VCRA

Vocera

$33.33 /

+0.38 (+1.15%)

Stephens analyst Scott…

Stephens analyst Scott Schoenhaus initiated coverage of Vocera with an Overweight rating and $40 price target. The stock is trading in line with healthcare IT peers and its own historic average multiple, which he views as unwarranted given the view that the company's growth opportunities centered around streamlined clinical communications are "even more important in the near term," Schoenhaus tells investors. He sees the ongoing shift to more software based services as providing higher-margin and more recurring revenue streams, the analyst added.

ShowHide Related Items >><<
VCRA Vocera
$33.33 /

+0.38 (+1.15%)

VCRA Vocera
$33.33 /

+0.38 (+1.15%)

10/30/20 Piper Sandler
Vocera price target raised to $41 from $28 at Piper Sandler
07/28/20
Fly Intel: Top five analyst upgrades
07/28/20 Craig-Hallum
Vocera upgraded to Buy from Hold at Craig-Hallum
07/28/20 RBC Capital
Vocera price target raised to $27 from $20 at RBC Capital
VCRA Vocera
$33.33 /

+0.38 (+1.15%)

VCRA Vocera
$33.33 /

+0.38 (+1.15%)

Over a month ago
Recommendations
Vocera price target raised to $41 from $28 at Piper Sandler » 05:00
10/30/20
10/30
05:00
10/30/20
05:00
VCRA

Vocera

$35.09 /

+1.16 (+3.42%)

Piper Sandler analyst…

Piper Sandler analyst Sean Wieland raised the firm's price target on Vocera to $41 from $28 and reiterates an Overweight rating on the shares. The company last night posted it strongest bookings performance in many years, Wieland tells investors in a research note. The analyst estimates bookings growth was 45% year-over-year and offers "strong visibility" to 300 basis points of revenue acceleration in 2021.

ShowHide Related Items >><<
VCRA Vocera
$35.09 /

+1.16 (+3.42%)

VCRA Vocera
$35.09 /

+1.16 (+3.42%)

07/28/20
Fly Intel: Top five analyst upgrades
07/28/20 Craig-Hallum
Vocera upgraded to Buy from Hold at Craig-Hallum
07/28/20 RBC Capital
Vocera price target raised to $27 from $20 at RBC Capital
07/28/20 Piper Sandler
Vocera price target raised to $28 from $26 at Piper Sandler
VCRA Vocera
$35.09 /

+1.16 (+3.42%)

VCRA Vocera
$35.09 /

+1.16 (+3.42%)

Earnings
Vocera reports Q3 EPS 31c, consensus 13c » 16:14
10/29/20
10/29
16:14
10/29/20
16:14
VCRA

Vocera

$35.00 /

+1.075 (+3.17%)

Reports Q3 revenue…

Reports Q3 revenue $53.8M, consensus $50.55M. "Q3 was an outstanding quarter for us, driven by tremendous success with Veterans Administration hospitals and large customer expansions," said Brent Lang, Chairman and CEO. "Despite another quarter of dealing with the COVID-19 pandemic, our teams remain focused on serving customers and supporting one another, and our connection to our mission has never been stronger."

ShowHide Related Items >><<
VCRA Vocera
$35.00 /

+1.075 (+3.17%)

VCRA Vocera
$35.00 /

+1.075 (+3.17%)

07/28/20
Fly Intel: Top five analyst upgrades
07/28/20 Craig-Hallum
Vocera upgraded to Buy from Hold at Craig-Hallum
07/28/20 RBC Capital
Vocera price target raised to $27 from $20 at RBC Capital
07/28/20 Piper Sandler
Vocera price target raised to $28 from $26 at Piper Sandler
VCRA Vocera
$35.00 /

+1.075 (+3.17%)

VCRA Vocera
$35.00 /

+1.075 (+3.17%)

Conference/Events
Morgan Stanley to hold a virtual conference » 08:45
09/14/20
09/14
08:45
09/14/20
08:45
STE

Steris

$162.23 /

+0.16 (+0.10%)

, HUM

Humana

$391.54 /

-1.795 (-0.46%)

, REGN

Regeneron

$544.64 /

-6.57 (-1.19%)

, IRWD

Ironwood

$9.73 /

+0.14 (+1.46%)

, MRNA

Moderna

$59.43 /

+1.88 (+3.27%)

, BIIB

Biogen

$270.00 /

+3.03 (+1.13%)

, CNC

Centene

$56.47 /

-0.62 (-1.09%)

, CYTK

Cytokinetics

$22.55 /

-0.28 (-1.23%)

, OPCH

Option Care Health

$10.71 /

-0.195 (-1.79%)

, PODD

Insulet

$211.98 /

-1.16 (-0.54%)

, TBPH

Theravance Biopharma

$16.89 /

-0.07 (-0.41%)

, MDT

Medtronic

$104.81 /

+0.02 (+0.02%)

, RMD

ResMed

$172.00 /

-0.3 (-0.17%)

, ONEM

1Life Healthcare

$27.57 /

-0.77 (-2.72%)

, NSTG

NanoString

$39.97 /

-0.32 (-0.79%)

, HRC

Hill-Rom

$87.42 /

-0.68 (-0.77%)

, NUVA

NuVasive

$53.95 /

+1.33 (+2.53%)

, VCRA

Vocera

$26.85 /

+0.3 (+1.13%)

, NTRA

Natera

$59.61 /

-2.19 (-3.54%)

, CAH

Cardinal Health

$48.38 /

-0.17 (-0.35%)

, DNLI

Denali Therapeutics

$31.96 /

-0.09 (-0.28%)

, ZEAL

Zealand Pharma

$34.97 /

+ (+0.00%)

, IART

Integra LifeSciences

$43.39 /

+0.06 (+0.14%)

18th Annual Global…

18th Annual Global Healthcare Virtual Conference will be held on September 14-18 with webcasted presentations to begin on September 14 at 9 am. Webcast Link

ShowHide Related Items >><<
ZEAL Zealand Pharma
$34.97 /

+ (+0.00%)

VCRA Vocera
$26.85 /

+0.3 (+1.13%)

TBPH Theravance Biopharma
$16.89 /

-0.07 (-0.41%)

STE Steris
$162.23 /

+0.16 (+0.10%)

RMD ResMed
$172.00 /

-0.3 (-0.17%)

REGN Regeneron
$544.64 /

-6.57 (-1.19%)

PODD Insulet
$211.98 /

-1.16 (-0.54%)

OPCH Option Care Health
$10.71 /

-0.195 (-1.79%)

ONEM 1Life Healthcare
$27.57 /

-0.77 (-2.72%)

NUVA NuVasive
$53.95 /

+1.33 (+2.53%)

NTRA Natera
$59.61 /

-2.19 (-3.54%)

NSTG NanoString
$39.97 /

-0.32 (-0.79%)

MRNA Moderna
$59.43 /

+1.88 (+3.27%)

MDT Medtronic
$104.81 /

+0.02 (+0.02%)

IRWD Ironwood
$9.73 /

+0.14 (+1.46%)

IART Integra LifeSciences
$43.39 /

+0.06 (+0.14%)

HUM Humana
$391.54 /

-1.795 (-0.46%)

HRC Hill-Rom
$87.42 /

-0.68 (-0.77%)

DNLI Denali Therapeutics
$31.96 /

-0.09 (-0.28%)

CYTK Cytokinetics
$22.55 /

-0.28 (-1.23%)

CNC Centene
$56.47 /

-0.62 (-1.09%)

CAH Cardinal Health
$48.38 /

-0.17 (-0.35%)

BIIB Biogen
$270.00 /

+3.03 (+1.13%)

STE Steris
$162.23 /

+0.16 (+0.10%)

09/01/20 Baird
Steris initiated with an Outperform at Baird
06/09/20 Needham
Steris initiated with a Hold at Needham
05/15/20 Stephens
Steris price target raised to $170 from $145 at Stephens
HUM Humana
$391.54 /

-1.795 (-0.46%)

09/10/20 Deutsche Bank
Humana price target raised to $431 from $397 at Deutsche Bank
08/26/20 JPMorgan
Biden policies 'current overhang' on Managed Care sector, says JPMorgan
08/18/20 JPMorgan
Humana price target raised to $452 from $394 at JPMorgan
08/17/20 RBC Capital
Humana price target raised to $420 from $388 at RBC Capital
REGN Regeneron
$544.64 /

-6.57 (-1.19%)

09/10/20 Benchmark
Vaccine may be approved before Regeneron's COVID therapeutic, says Benchmark
09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/20/20 Benchmark
Regeneron downgraded to Hold from Buy at Benchmark
08/20/20 Benchmark
Regeneron downgraded to Hold from Buy at Benchmark
IRWD Ironwood
$9.73 /

+0.14 (+1.46%)

06/17/20 Northland
Northland starts Ironwood at Outperform, sees long runway for Linzess
06/17/20 Northland
Ironwood initiated with an Outperform at Northland
MRNA Moderna
$59.43 /

+1.88 (+3.27%)

09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/08/20
Fly Intel: Top five analyst downgrades
09/08/20 B. Riley Securities
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
09/08/20 SVB Leerink
Moderna downgraded to sell on rising vaccine competition at SVB Leerink
BIIB Biogen
$270.00 /

+3.03 (+1.13%)

08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Piper Sandler
Mylan launch puts 30% of Biogen revenue base at risk, says Piper Sandler
08/07/20 Credit Suisse
Credit Suisse upgrades Biogen after 'best case scenario' for aducanumab BLA
08/07/20 Credit Suisse
Biogen upgraded to Outperform from Neutral at Credit Suisse
CNC Centene
$56.47 /

-0.62 (-1.09%)

08/17/20
Loeb's Third Point buys Alibaba, makes a top holding, during second quarter
07/29/20 Deutsche Bank
Centene price target raised to $87 from $80 at Deutsche Bank
07/01/20 SVB Leerink
Centene reinstated with an Outperform at SVB Leerink
CYTK Cytokinetics
$22.55 /

-0.28 (-1.23%)

07/23/20 H.C. Wainwright
Cytokinetics price target raised to $59 from $38 at H.C. Wainwright
07/23/20 Piper Sandler
Cytokinetics price target raised to $36 from $33 at Piper Sandler
07/16/20 Needham
Cytokinetics price target raised to $45 from $34 at Needham
07/15/20 Cantor Fitzgerald
Cytokinetics price target raised to $41 from $29 at Cantor Fitzgerald
OPCH Option Care Health
$10.71 /

-0.195 (-1.79%)

08/05/20 Barrington
Option Care Health price target raised to $19 from $17 at Barrington
07/27/20 Lake Street
Option Care Health weakness a buying opportunity, says Lake Street
06/29/20 Lake Street
Option Care Health should be bought on S-3 filing dip, says Lake Street
06/24/20 BofA
Option Care Health initiated with a Buy at BofA
PODD Insulet
$211.98 /

-1.16 (-0.54%)

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
08/07/20 Stephens
Insulet price target raised to $230 from $165 at Stephens
08/07/20 Citi
Insulet price target raised to $255 from $200 at Citi
08/06/20 Piper Sandler
Insulet price target raised to $260 from $235 at Piper Sandler
TBPH Theravance Biopharma
$16.89 /

-0.07 (-0.41%)

08/07/20 Piper Sandler
Theravance Biopharma price target lowered to $30 from $35 at Piper Sandler
07/07/20 JPMorgan
Theravance Biopharma initiated with an Overweight at JPMorgan
06/15/20 Morgan Stanley
Theravance Biopharma initiated with an Equal Weight at Morgan Stanley
04/09/20 Piper Sandler
Theravance joining fight against COVID-19 with TD-0903, says Piper Sandler
MDT Medtronic
$104.81 /

+0.02 (+0.02%)

09/11/20 Wolfe Research
Medtronic initiated with a Peer Perform at Wolfe Research
08/26/20 Raymond James
Medtronic price target raised to $115 from $107 at Raymond James
08/26/20 BTIG
Medtronic price target raised to $111 from $102 at BTIG
08/26/20 Citi
Medtronic price target raised to $120 from $108 at Citi
RMD ResMed
$172.00 /

-0.3 (-0.17%)

08/06/20 Morgan Stanley
ResMed downgraded to Equal Weight from Overweight at Morgan Stanley
08/06/20 Goldman Sachs
ResMed downgraded to Neutral from Buy at Goldman Sachs
08/06/20 Oppenheimer
ResMed price target raised to $212 from $200 at Oppenheimer
08/03/20 BofA
ResMed downgraded to Underperform from Buy at BofA
ONEM 1Life Healthcare
$27.57 /

-0.77 (-2.72%)

08/14/20 Truist
One Medical price target raised to $36 from $30 at Truist
07/17/20 Piper Sandler
1Life Healthcare price target raised to $43 from $40 at Piper Sandler
07/08/20 Citi
1Life Healthcare price target raised to $38 from $20 at Citi
07/01/20 SVB Leerink
SVB Leerink starts 1Life with a Market Perform given unclear profitability path
NSTG NanoString
$39.97 /

-0.32 (-0.79%)

09/09/20 Morgan Stanley
Veracyte initiated with an Underweight at Morgan Stanley
09/09/20 Morgan Stanley
NanoString initiated with an Equal Weight at Morgan Stanley
05/11/20 Baird
NanoString price target raised to $34 from $29 at Baird
03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
HRC Hill-Rom
$87.42 /

-0.68 (-0.77%)

09/01/20 Baird
Hill-Rom initiated with an Outperform at Baird
08/17/20 BofA
Medtronic added to US 1 List, Hill-Rom removed at BofA
08/03/20 Stifel
Hill-Rom should be bought on post-earnings pullback, says Stifel
07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
NUVA NuVasive
$53.95 /

+1.33 (+2.53%)

07/20/20 Piper Sandler
NuVasive Q2 pre-announcement 'considerably' better than expected, says Piper
06/25/20 Northland
NuVasive initiated with a Market Perform at Northland
06/23/20
Fly Intel: Top five analyst upgrades
06/23/20 Needham
NuVasive upgraded to Buy from Hold at Needham
VCRA Vocera
$26.85 /

+0.3 (+1.13%)

07/28/20
Fly Intel: Top five analyst upgrades
07/28/20 Craig-Hallum
Vocera upgraded to Buy from Hold at Craig-Hallum
07/28/20 RBC Capital
Vocera price target raised to $27 from $20 at RBC Capital
07/28/20 Piper Sandler
Vocera price target raised to $28 from $26 at Piper Sandler
NTRA Natera
$59.61 /

-2.19 (-3.54%)

09/03/20 Piper Sandler
Natera received final Medicare coverage from Palmetto, says Piper Sandler
09/02/20 Canaccord
Natera price target raised to $72 from $65 at Canaccord
08/18/20 Canaccord
Natera stands to benefit disproportionately from ACOG ruling, says Canaccord
08/17/20 Piper Sandler
ACOG recommendation 'extremely' positive for Natera and Progenity, says Piper
CAH Cardinal Health
$48.38 /

-0.17 (-0.35%)

07/20/20
Fly Intel: Top five analyst upgrades
07/20/20 Guggenheim
Guggenheim upgrades Cardinal Health to Buy as healthcare environment normalizes
07/20/20 Guggenheim
Cardinal Health upgraded to Buy from Neutral at Guggenheim
06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
DNLI Denali Therapeutics
$31.96 /

-0.09 (-0.28%)

09/14/20 JPMorgan
Denali Therapeutics resumed with an Overweight at JPMorgan
08/20/20 H.C. Wainwright
Denali Therapeutics price target raised to $45 from $28 at H.C. Wainwright
08/06/20 Goldman Sachs
Denali's LRRK2 program complementary to Biogen's PD pipeline, says Goldman Sachs
08/06/20 Wells Fargo
Biogen 'doubling down on LRRK2' via deal with Denali, says Wells Fargo
ZEAL Zealand Pharma
$34.97 /

+ (+0.00%)

03/10/20 Morgan Stanley
Zealand Pharma EPS estimates cut at Morgan Stanley
11/19/19 Jefferies
Zealand Pharma downgraded to Hold from Buy at Jefferies
11/15/19 Needham
Zealand Pharma price target raised to $42 from $32 at Needham
10/15/19
Fly Intel: Top five analyst upgrades
IART Integra LifeSciences
$43.39 /

+0.06 (+0.14%)

08/12/20 Truist
Integra LifeSciences price target raised to $60 from $55 at Truist
08/11/20 Oppenheimer
Integra LifeSciences price target raised to $68 from $60 at Oppenheimer
07/09/20 Piper Sandler
Piper Sandler remains 'apprehensive' on Integra LifeSciences after Q2 revenue
05/27/20
Fly Intel: Top five analyst initiations
ZEAL Zealand Pharma
$34.97 /

+ (+0.00%)

VCRA Vocera
$26.85 /

+0.3 (+1.13%)

TBPH Theravance Biopharma
$16.89 /

-0.07 (-0.41%)

STE Steris
$162.23 /

+0.16 (+0.10%)

RMD ResMed
$172.00 /

-0.3 (-0.17%)

REGN Regeneron
$544.64 /

-6.57 (-1.19%)

PODD Insulet
$211.98 /

-1.16 (-0.54%)

OPCH Option Care Health
$10.71 /

-0.195 (-1.79%)

ONEM 1Life Healthcare
$27.57 /

-0.77 (-2.72%)

NUVA NuVasive
$53.95 /

+1.33 (+2.53%)

NTRA Natera
$59.61 /

-2.19 (-3.54%)

NSTG NanoString
$39.97 /

-0.32 (-0.79%)

MRNA Moderna
$59.43 /

+1.88 (+3.27%)

MDT Medtronic
$104.81 /

+0.02 (+0.02%)

IRWD Ironwood
$9.73 /

+0.14 (+1.46%)

IART Integra LifeSciences
$43.39 /

+0.06 (+0.14%)

HUM Humana
$391.54 /

-1.795 (-0.46%)

HRC Hill-Rom
$87.42 /

-0.68 (-0.77%)

DNLI Denali Therapeutics
$31.96 /

-0.09 (-0.28%)

CYTK Cytokinetics
$22.55 /

-0.28 (-1.23%)

CNC Centene
$56.47 /

-0.62 (-1.09%)

CAH Cardinal Health
$48.38 /

-0.17 (-0.35%)

BIIB Biogen
$270.00 /

+3.03 (+1.13%)

  • 11
    Sep
  • 22
    Jul
  • 17
    Jul
  • 25
    Jun
  • 27
    May
  • 19
    May
  • 13
    May
  • 12
    Feb
  • 12
    Feb
  • 29
    Jan
  • 31
    Jan
  • 17
    Oct
  • 15
    Oct
TBPH Theravance Biopharma
$16.89 /

-0.07 (-0.41%)

REGN Regeneron
$544.64 /

-6.57 (-1.19%)

MRNA Moderna
$59.43 /

+1.88 (+3.27%)

MDT Medtronic
$104.81 /

+0.02 (+0.02%)

HUM Humana
$391.54 /

-1.795 (-0.46%)

CAH Cardinal Health
$48.38 /

-0.17 (-0.35%)

BIIB Biogen
$270.00 /

+3.03 (+1.13%)

VCRA Vocera
$26.85 /

+0.3 (+1.13%)

RMD ResMed
$172.00 /

-0.3 (-0.17%)

REGN Regeneron
$544.64 /

-6.57 (-1.19%)

PODD Insulet
$211.98 /

-1.16 (-0.54%)

OPCH Option Care Health
$10.71 /

-0.195 (-1.79%)

ONEM 1Life Healthcare
$27.57 /

-0.77 (-2.72%)

NSTG NanoString
$39.97 /

-0.32 (-0.79%)

MRNA Moderna
$59.43 /

+1.88 (+3.27%)

MDT Medtronic
$104.81 /

+0.02 (+0.02%)

IRWD Ironwood
$9.73 /

+0.14 (+1.46%)

IART Integra LifeSciences
$43.39 /

+0.06 (+0.14%)

HUM Humana
$391.54 /

-1.795 (-0.46%)

DNLI Denali Therapeutics
$31.96 /

-0.09 (-0.28%)

CYTK Cytokinetics
$22.55 /

-0.28 (-1.23%)

CNC Centene
$56.47 /

-0.62 (-1.09%)

CAH Cardinal Health
$48.38 /

-0.17 (-0.35%)

BIIB Biogen
$270.00 /

+3.03 (+1.13%)

REGN Regeneron
$544.64 /

-6.57 (-1.19%)

ONEM 1Life Healthcare
$27.57 /

-0.77 (-2.72%)

MRNA Moderna
$59.43 /

+1.88 (+3.27%)

MDT Medtronic
$104.81 /

+0.02 (+0.02%)

HUM Humana
$391.54 /

-1.795 (-0.46%)

CNC Centene
$56.47 /

-0.62 (-1.09%)

CAH Cardinal Health
$48.38 /

-0.17 (-0.35%)

BIIB Biogen
$270.00 /

+3.03 (+1.13%)

Conference/Events
Baird to hold a virtual conference » 04:55
09/10/20
09/10
04:55
09/10/20
04:55
VCRA

Vocera

$27.09 /

-0.09 (-0.33%)

, EVH

Evolent Health

$13.40 /

+0.175 (+1.32%)

, HCA

HCA Healthcare

$133.89 /

+1.4 (+1.06%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2020 will be held on September 9-10.

ShowHide Related Items >><<
VCRA Vocera
$27.09 /

-0.09 (-0.33%)

HCA HCA Healthcare
$133.89 /

+1.4 (+1.06%)

EVH Evolent Health
$13.40 /

+0.175 (+1.32%)

VCRA Vocera
$27.09 /

-0.09 (-0.33%)

07/28/20
Fly Intel: Top five analyst upgrades
07/28/20 Craig-Hallum
Vocera upgraded to Buy from Hold at Craig-Hallum
07/28/20 RBC Capital
Vocera price target raised to $27 from $20 at RBC Capital
07/28/20 Piper Sandler
Vocera price target raised to $28 from $26 at Piper Sandler
EVH Evolent Health
$13.40 /

+0.175 (+1.32%)

08/05/20 Canaccord
Evolent Health price target raised to $16 from $13 at Canaccord
08/05/20 Truist
Evolent Health price target raised to $20 from $15 at Truist
08/05/20 Cantor Fitzgerald
Evolent Health price target raised to $13 from $10 at Cantor Fitzgerald
07/06/20 KeyBanc
Evolent Health downgraded to Sector Weight from Overweight at KeyBanc
HCA HCA Healthcare
$133.89 /

+1.4 (+1.06%)

07/24/20 JPMorgan
HCA Healthcare price target raised to $161 from $142 at JPMorgan
07/23/20 Oppenheimer
HCA Healthcare price target raised to $140 from $135 at Oppenheimer
07/23/20 Deutsche Bank
HCA Healthcare price target raised to $150 from $132 at Deutsche Bank
07/23/20 Raymond James
HCA Healthcare price target raised to $140 from $130 at Raymond James
VCRA Vocera
$27.09 /

-0.09 (-0.33%)

HCA HCA Healthcare
$133.89 /

+1.4 (+1.06%)

EVH Evolent Health
$13.40 /

+0.175 (+1.32%)

HCA HCA Healthcare
$133.89 /

+1.4 (+1.06%)

EVH Evolent Health
$13.40 /

+0.175 (+1.32%)

VCRA Vocera
$27.09 /

-0.09 (-0.33%)

HCA HCA Healthcare
$133.89 /

+1.4 (+1.06%)

EVH Evolent Health
$13.40 /

+0.175 (+1.32%)

HCA HCA Healthcare
$133.89 /

+1.4 (+1.06%)

Conference/Events
Baird to hold a virtual conference » 08:22
09/09/20
09/09
08:22
09/09/20
08:22
VCRA

Vocera

$27.18 /

-0.505 (-1.82%)

, EVH

Evolent Health

$13.22 /

-0.54 (-3.92%)

, HCA

HCA Healthcare

$132.51 /

-4.74 (-3.45%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2020 will be held on September 9-10.

ShowHide Related Items >><<
VCRA Vocera
$27.18 /

-0.505 (-1.82%)

HCA HCA Healthcare
$132.51 /

-4.74 (-3.45%)

EVH Evolent Health
$13.22 /

-0.54 (-3.92%)

VCRA Vocera
$27.18 /

-0.505 (-1.82%)

07/28/20
Fly Intel: Top five analyst upgrades
07/28/20 Craig-Hallum
Vocera upgraded to Buy from Hold at Craig-Hallum
07/28/20 RBC Capital
Vocera price target raised to $27 from $20 at RBC Capital
07/28/20 Piper Sandler
Vocera price target raised to $28 from $26 at Piper Sandler
EVH Evolent Health
$13.22 /

-0.54 (-3.92%)

08/05/20 Canaccord
Evolent Health price target raised to $16 from $13 at Canaccord
08/05/20 Truist
Evolent Health price target raised to $20 from $15 at Truist
08/05/20 Cantor Fitzgerald
Evolent Health price target raised to $13 from $10 at Cantor Fitzgerald
07/06/20 KeyBanc
Evolent Health downgraded to Sector Weight from Overweight at KeyBanc
HCA HCA Healthcare
$132.51 /

-4.74 (-3.45%)

07/24/20 JPMorgan
HCA Healthcare price target raised to $161 from $142 at JPMorgan
07/23/20 Oppenheimer
HCA Healthcare price target raised to $140 from $135 at Oppenheimer
07/23/20 Deutsche Bank
HCA Healthcare price target raised to $150 from $132 at Deutsche Bank
07/23/20 Raymond James
HCA Healthcare price target raised to $140 from $130 at Raymond James
VCRA Vocera
$27.18 /

-0.505 (-1.82%)

HCA HCA Healthcare
$132.51 /

-4.74 (-3.45%)

EVH Evolent Health
$13.22 /

-0.54 (-3.92%)

HCA HCA Healthcare
$132.51 /

-4.74 (-3.45%)

EVH Evolent Health
$13.22 /

-0.54 (-3.92%)

VCRA Vocera
$27.18 /

-0.505 (-1.82%)

HCA HCA Healthcare
$132.51 /

-4.74 (-3.45%)

EVH Evolent Health
$13.22 /

-0.54 (-3.92%)

HCA HCA Healthcare
$132.51 /

-4.74 (-3.45%)

Over a quarter ago
Hot Stocks
Vocera acquires EASE Applications, issues 60,000 shares to its employees » 08:08
08/19/20
08/19
08:08
08/19/20
08:08
VCRA

Vocera

$29.33 /

+0.83 (+2.91%)

Vocera announced that it…

Vocera announced that it has acquired EASE Applications, based in Orlando, Florida. EASE offers a cloud-based communication platform and mobile application built to improve the patient experience by enabling friends and family members to receive timely updates about the progress of their loved one in the hospital. The EASE app enables nurses and other care team members to send HIPAA-compliant texts, photos and video updates to patients' loved ones, putting them at ease and saving valuable time. With more than 1.6M sent messages, the EASE application has demonstrated improved patient and family satisfaction and reduced the number of phone calls from loved ones to the hospital. In one study with approximately 2,500 family members, 98% said that EASE reduced their anxiety, and 81% reported that the availability of EASE would influence their choice of hospital. Additionally, patient satisfaction scores increased by an average of 6% for patients who used EASE compared to patients who did not use the application. As part of the onboarding process, Vocera will issue restricted stock units totaling approximately 60,000 shares of Vocera common stock to approximately eleven employees of EASE. These restricted stock units will vest over three years after the closing and will be made from an inducement plan adopted by the company's board of directors pursuant to the inducement exemption provided under the NYSE listing rules.

ShowHide Related Items >><<
VCRA Vocera
$29.33 /

+0.83 (+2.91%)

VCRA Vocera
$29.33 /

+0.83 (+2.91%)

07/28/20
Fly Intel: Top five analyst upgrades
07/28/20 Craig-Hallum
Vocera upgraded to Buy from Hold at Craig-Hallum
07/28/20 RBC Capital
Vocera price target raised to $27 from $20 at RBC Capital
07/28/20 Piper Sandler
Vocera price target raised to $28 from $26 at Piper Sandler
VCRA Vocera
$29.33 /

+0.83 (+2.91%)

VCRA Vocera
$29.33 /

+0.83 (+2.91%)

Conference/Events
Vocera participates in a conference call hosted by Cantor Fitzgerald » 12:55
08/03/20
08/03
12:55
08/03/20
12:55
VCRA

Vocera

$31.27 /

+0.49 (+1.59%)

Cantor Fitzgerald holds a…

Cantor Fitzgerald holds a conference call with management on August 3 at 2pm.

ShowHide Related Items >><<
VCRA Vocera
$31.27 /

+0.49 (+1.59%)

VCRA Vocera
$31.27 /

+0.49 (+1.59%)

07/28/20
Fly Intel: Top five analyst upgrades
07/28/20 Craig-Hallum
Vocera upgraded to Buy from Hold at Craig-Hallum
07/28/20 RBC Capital
Vocera price target raised to $27 from $20 at RBC Capital
07/28/20 Piper Sandler
Vocera price target raised to $28 from $26 at Piper Sandler
VCRA Vocera
$31.27 /

+0.49 (+1.59%)

VCRA Vocera
$31.27 /

+0.49 (+1.59%)

Conference/Events
Vocera participates in a conference call hosted by Cantor Fitzgerald » 04:55
08/03/20
08/03
04:55
08/03/20
04:55
VCRA

Vocera

$30.78 /

-0.11 (-0.36%)

Cantor Fitzgerald holds a…

Cantor Fitzgerald holds a conference call with management on August 3 at 2pm.

ShowHide Related Items >><<
VCRA Vocera
$30.78 /

-0.11 (-0.36%)

VCRA Vocera
$30.78 /

-0.11 (-0.36%)

07/28/20
Fly Intel: Top five analyst upgrades
07/28/20 Craig-Hallum
Vocera upgraded to Buy from Hold at Craig-Hallum
07/28/20 RBC Capital
Vocera price target raised to $27 from $20 at RBC Capital
07/28/20 Piper Sandler
Vocera price target raised to $28 from $26 at Piper Sandler
VCRA Vocera
$30.78 /

-0.11 (-0.36%)

VCRA Vocera
$30.78 /

-0.11 (-0.36%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.